Search results
Aktis to collaborate with Eli Lilly on cancer therapies
AOL· 52 minutes agoThe Boston-based drug developer will use its proprietary technology along with Lilly's expertise in oncology drugs to develop therapies for a range of solid tumors. The company ...
Eli Lilly's diabetes drug tirzepatide gets approval in China By Reuters
Investing.com· 4 hours agoEli Lilly (NYSE:LLY) said on Tuesday its diabetes drug tirzepatide has received approval from...
China Clears Eli Lilly’s Weight-Loss Drug, Only for Diabetes Now
Bloomberg· 3 hours agoHave a confidential tip for our reporters? China gave the greenlight to Eli Lilly & Co.’s...
Analyzing Lilly(Eli) & Co
Knox Daily· 5 hours agoLilly(Eli) & Co’s recently made public that its SVP, Finance, & CAO Zakrowski Donald A unloaded Company’s shares for reported $0.57 million on Mar 11 ’24 ...
'Ozempic breasts' to 'Ozempic face': What you need to know about weight loss drug side effects
Euronews via Yahoo News· 2 days agoFor instance, in 2023, American Jaclyn Bjorklund launched legal proceedings against Novo Nordisk and...
Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
WHTC 1450 Holland· 7 days ago(Reuters) - Eli Lilly has entered into a settlement deal with a medi spa that had sold counterfeit...
Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Investor's Business Daily· 6 days agoEli Lilly stock yo-yoed recently after announcing the Food and Drug Administration has scheduled an...
Eli Lilly stock maintains price target with Jefferies' buy rating By Investing.com
Investing.com· 1 day agoOn Monday, Jefferies maintained a confident stance on Eli Lilly (NYSE:LLY) shares, reiterating a Buy rating and a price target of $915.00. The affirmation ...
Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market? | The Motley Fool
The Motley Fool· 2 days agoEli Lilly (LLY 1.71%) sells a broad portfolio of products, but two in particular have helped revenue...
Eli Lilly says its experimental weekly insulin works just as well as daily doses
Quartz· 5 days agoPeople who depend on daily insulin shots may soon have welcome news: a new experimental drug could...